Treatment Outcomes for Adults and Adolescents in Mental Health Residential and Day Treatment
Skyland Trail is a trailblazer in the area of outcomes research, which is an integral part of our evidence-based treatment model. Our robust outcomes and research program employs evaluative instruments considered to be the gold standards in the mental health field to measure the effectiveness of our treatment programs.
Most patients have reduced symptoms as a result of treatment, and our outcomes data indicate that many patients make even more progress. They experience a clinically meaningful change – one that science has shown impacts how a patient feels and functions.
For many patients, this also means achieving remission. Based on cutoffs established in the psychiatric literature, remission means that the level of symptoms present no longer meets criteria for the diagnosis.
2025 Adult Patient Outcomes
Patients who completed assessment at discharge in 2025
Adult Patients with Depression-Related Disorders
Approximately 86% of adult patients admitting in 2025 reported major depression, bipolar disorder, or a related mood disorder as a primary diagnosis.
% Reduction in Depression Symptoms
46%
On average, patients experienced a 46% reduction in depression symptoms
Includes patients with primary mood disorders as well as patients with primary psychosis-related and anxiety-related disorders.
% Patients With Minimal Symptoms at Discharge
41%
Approximately 41% of patients experienced minimal depression symptoms at discharge
Adult Patients with Anxiety Disorders
Approximately 61% of adult patients admitting in 2025 reported an anxiety disorder as a primary or co-occurring diagnosis.
% Reduction in Anxiety Symptoms
44%
On average, adult patients experienced a 44% reduction in anxiety symptoms
% Patients with Minimal Symptoms at Discharge
42%
Approximately 42% of patients experienced minimal anxiety symptoms at discharge
Emotion Regulation
Improved Emotion Regulation
72%
On average, 72% of patients experienced clinically meaningful improvement in emotion regulation
Functional Impairment
Reduced Functional Impairment
22%
On average, 22% of patients experienced a reduction in functional impairment
2025 Adolescent Patient Outcomes
PATIENTS WHO COMPLETED ASSESSMENTS AT DISCHARGE IN 2025
Adolescent Patients with Depression-Related Disorders
Approximately 94% of adolescent patients admitting in 2025 reported major depression, bipolar disorder, or a related mood disorder as a primary diagnosis.
% Reduction in Symptoms
58%
On average, patients experienced a 58% reduction in depression symptoms
% Minimal Symptoms at Discharge
66%
Approximately 66% of patients experienced minimal depression symptoms at discharge
Adolescent Patients with Anxiety Disorders
Approximately 75% of adolescent patients admitting in 2025 reported an anxiety disorder as a primary or co-occurring diagnosis.
% Reduction in Symptoms
23%
On average, patients experienced a 23% reduction in anxiety symptoms
% Minimal Symptoms at Discharge
29%
Approximately 29% of adolescent patients experienced anxiety below the population average at discharge
Adolescent Patients with Trauma-Related Disorders
Approximately 32% of adolescent patients admitting in 2025 reported PTSD or a trauma-related disorder as a primary or co-occurring diagnosis.
% Reduction in Symptoms
90%
90% of patients who completed Prolonged Exposure Therapy in 2025 saw clinically significant reduction
in PTSD symptoms during treatment7
Outcomes Report 2024
View outcomes data to see the kinds or improvements our clients make by engaging in treatment.